Can venture capital drive innovation in the autism field, as it has in other fields? Can the dynamism of capital markets be applied to autism’s stubborn challenges of diagnosis, therapies, services and employment?
In the past few years, several autism-focused venture capital funds have been launched, including Moai Capital, Autism Impact Fund, and Neuvation Ventures. Their founders and chief leaders have family members on the autism spectrum, and come to their funds with a strong sense of mission and urgency. The funds are structured as traditional venture capital funds, aiming to maximize investor returns, but with focus on products for improving the lives of individuals with autism.
Support authors and subscribe to content
This is premium stuff. Subscribe to read the entire article.